In this article, we will look at 5 dividend stocks in Billionaire Richard Chilton’s Portfolio. If you want to see our detailed analysis of these stocks, Chilton Investment Company’s past performance, and billionaire Richard Chilton’s investment philosophy, you can head on to 10 Dividend Stocks in Billionaire Richard Chilton’s Portfolio.
5. Magellan Midstream Partners, L.P. (NYSE:MMP)
Stake Value of Chilton Investment Company: $740,000
Percentage of Chilton Investment Company’s 13F Portfolio: 0.01%
Number of Hedge Fund Holders: 12
Dividend Yield as of December 11: 9.12%
Magellan Midstream Partners, L.P. (NYSE:MMP) engages in the transportation, storage, and distribution of refined petroleum products and crude oil in the United States. The company operates through Refined Products and Crude Oil segments.
On November 11th, Mizuho analyst Gabriel Moreen raised the price target on Magellan Midstream Partners, L.P. (NYSE:MMP) to $52 from $50 and reiterated a Neutral rating on the shares in light of the company’s third-quarter earnings.
By the end of the third quarter of 2021, Insider Monkey was able to identify 12 hedge funds that held stakes in Magellan Midstream Partners, L.P. (NYSE:MMP). The total value of these stakes was $92.09 million, up from $89.13 million in the previous quarter.
4. Blackstone Mortgage Trust Inc (NYSE:BXMT)
Stake Value of Chilton Investment Company: $1,804,000
Percentage of Chilton Investment Company’s 13F Portfolio: 0.04%
Number of Hedge Fund Holders: 15
Dividend Yield as of December 11: 8.15%
Blackstone Mortgage Trust Inc (NYSE:BXMT) operates as a real estate finance company that originates senior loans collateralized by commercial properties in North America, Europe, and Australia. The stock has a forward dividend yield of 8.15%, and a price-to-earnings ratio of 12.41 as of 11th December.
Blackstone Mortgage Trust Inc (NYSE:BXMT) was found to be a part of 15 hedge fund portfolios at the end of the September quarter. The hedge fund sentiment for the stock is positive, since in the second quarter of 2021, ending June, 12 hedge funds had stakes in Blackstone Mortgage Trust Inc (NYSE:BXMT). The 15 positions identified during the third quarter had total stakes of roughly $182 million in the company.
On 29th November Jade Rahmani, an analyst at Keefe Bruyette, upgraded Blackstone Mortgage Trust Inc (NYSE:BXMT) to Outperform from Market Perform and reiterated a price target of $34.
3. Merck & Co., Inc. (NYSE:MRK)
Stake Value of Chilton Investment Company: $2,239,000
Percentage of Chilton Investment Company’s 13F Portfolio: 0.05%
Number of Hedge Fund Holders: 77
Dividend Yield as of December 11: 3.80%
Merck & Co., Inc. (NYSE:MRK) operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. This December, Merck & Co., Inc. (NYSE:MRK) announced it has entered into an agreement with Thermo Fisher Scientific (NYSE:TMO) to manufacture molnupiravir, the company’s investigational oral antiviral medicine for the treatment of COVID-19.
On December 8th, Wells Fargo analyst Mohit Bansal initiated coverage of Merck & Co., Inc. (NYSE:MRK) with an Overweight rating and a $90 price target.
Artisan Partners published its first-quarter 2021 investor letter, in which the firm shared its views on Merck & Co., Inc. (NYSE:MRK). Here’s what the firm had to say:
“In Q1, we initiated a position in Merck, a provider of health care solutions including prescription medicines, vaccines, biologic therapies, animal health and consumer care products. We purchased Merck when the stock came under pressure in part on concerns that the newly minted Biden administration could implement regulatory changes and lower drug costs in the pharmaceutical industry. Recent, but anticipated changes to Merck’s management team have also weighed on shares, as have concerns over the company’s heavy reliance on immunotherapy treatment Keytruda. Notably, Merck is not getting much credit from investors for the 60+ programs it has in clinical development, despite having several solid and large new product opportunities. Additionally, the company’s strong balance sheet and robust free cash flow provide it multiple options for future
partnerships and acquisitions. While Merck is undergoing a period of transition, we think the company’s fundamentals are strong and believe changes to management should be a catalyst for improvement.”
2. Enterprise Products Partners L.P. (NYSE:EPD)
Stake Value of Chilton Investment Company: $2,147,000
Percentage of Chilton Investment Company’s 13F Portfolio: 0.05%
Number of Hedge Fund Holders: 25
Dividend Yield as of December 11: 8.41%
Enterprise Products Partners L.P. (NYSE:EPD) provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through four business segments: NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services.
On October 5th, Mizuho analyst Gabriel Moreen raised the price target on Enterprise Products Partners L.P. (NYSE:EPD) to $29 from $28 and reiterated a Buy rating on the shares.
By the end of the third quarter of 2021, 25 hedge funds had stakes in Enterprise Products Partners L.P. (NYSE:EPD). The total value of these stakes was $233.25 million.
ClearBridge Investments, an investment management firm, published its “Large Cap Value Strategy” first quarter 2021 investor letter in which it mentioned Enterprise Products Partners L.P. (NYSE:EPD). Here’s what they had to say:
“While reducing in health care and consumer staples, we increased our exposure to high-quality names in economically sensitive areas of the market. We added to low-cost, high-quality energy names (including) Enterprise Products Partners LP. We are positive on this company’s strong balance sheets, competitive positions and exposure to an economic recovery.”
1. New Mountain Finance Corp. (NYSE:NMFC)
Stake Value of Chilton Investment Company: $4,571,000
Percentage of Chilton Investment Company’s 13F Portfolio: 0.11%
Number of Hedge Fund Holders: 6
Dividend Yield as of December 11: 8.75%
New Mountain Finance Corp. (NYSE:NMFC) is a Business Development Company. It specializes in investments in middle-market companies and debt securities at various levels of the capital structure. The company invests in various industries that include software, education, business services, distribution and logistics, federal services, healthcare, energy, media, consumer and industrial services, specialty chemicals and materials, telecommunication, retail, and power generation.
This November, New Mountain Finance Corp. (NYSE:NMFC) reported its third-quarter earnings for 2021. The company reported an EPS of $0.28, and beat on revenue.
There were 6 hedge funds in Insider Monkey’s database that held stakes worth $13.9 million in New Mountain Finance Corp. (NYSE:NMFC) by the end of the third quarter of 2021.
You can also take a look at 15 Best Energy Stocks to Buy Now and 10 Best Construction Materials Stocks To Buy Now.
